TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive DeVita takes Over As NCI Acing Director; Search Begins For New Permanent Chief January 4, 1980
TCL Archive Lederberg Appointment As Panel Chairman Confirmed; Bernard Fisher will Be Names To The Other Vacancy November 30, 1979
TCL Archive Increase In Recommended Levels, OMB’s Forward Funding Create Shortfall In Center’s Budget April 19, 1985
